Large-scale testing (Phase 3)UnknownNCT02409199What this trial is testingApatinib Versus Docetaxol Patients With Advanced Gastric CancerWho this might be right forGastric Carcinoma Shanghai Zhongshan Hospital 66
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07243938What this trial is testingPhase II Basket Trial: Zanidatamab Plus Tislelizumab in HER2-Positive GI Tumors (UNION-HER2-BASKET)Who this might be right forLocally Advanced Rectal Cancer (LARC)Locally Advanced Gastric/Gastroesophageal Junction AdenocarcinomaMetastatic Colorectal Cancer (mCRC)+1 more Tao Zhang 70
Testing effectiveness (Phase 2)Looking for participantsNCT05671822What this trial is testingPh1b/2 Study of the Safety and Efficacy of SHR-A1811 Combinations in Advanced HER2 Expression Gastric CancerWho this might be right forHER2 Expression Gastric Cancer/Gastroesophageal Junction Adenocarcinoma Suzhou Suncadia Biopharmaceuticals Co., Ltd. 258
Early research (Phase 1)Active Not RecruitingNCT05614102What this trial is testingA First-in-human Study to Learn How Safe the Study Drug BAY2965501 is, Find the Best Dose (Single Drug & Combination), How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, How it Acts on Different Tumors in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors Bayer 284
Early research (Phase 1)Study completedNCT04513223What this trial is testingSHR-A1811 in Patients With Selected HER2 Expressing TumorsWho this might be right forGastric CancerColorectal Cancer Jiangsu HengRui Medicine Co., Ltd. 101
Large-scale testing (Phase 3)Looking for participantsNCT04342910What this trial is testingStudy to Evaluate the Efficacy and Safety of Camrelizumab and Apatinib in Patients With GC/GEJCWho this might be right forGastric Cancer Jiangsu HengRui Medicine Co., Ltd. 550
Not applicableLooking for participantsNCT06846996What this trial is testingReal-world Effectiveness and Safety of Trastuzumab Deruxtecan in Patients With Locally Advanced or Metastatic HER2-positive Gastric or Gastroesophageal Junction Adenocarcinoma in ChinaWho this might be right forHER2-positive Gastric CancerHER2-positive Gastroesophageal Junction Daiichi Sankyo 260
Testing effectiveness (Phase 2)UnknownNCT05918419What this trial is testingEfficacy and Safety of Neoadjuvant Chemoradiation Plus Serplulimab in Patients With Locally Advanced Adenocarcinoma of Gastroesophageal JunctionWho this might be right forGastroesophageal Junction Adenocarcinoma Peking Union Medical College Hospital 35
Large-scale testing (Phase 3)Looking for participantsNCT07315750What this trial is testingDisitamab Vedotin Combined With Trastuzumab and Tislelizumab Versus Chemotherapy Combined With Trastuzumab With or Without Pembrolizumab in HER2-high Expression Advanced Gastric or Gastroesophageal Junction Adenocarcinoma.Who this might be right forGastric Carcinoma RemeGen Co., Ltd. 555
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07050524What this trial is testingOmega-3 Supplementation and Immunotherapy in Gastric Cancer: A Phase II TrialWho this might be right forGastric Cancer Stage III The First Affiliated Hospital with Nanjing Medical University 80
Early research (Phase 1)Not Yet RecruitingNCT07358884What this trial is testingFirst in Human Study of QLS5316 in Solid TumorsWho this might be right forSolid TumorsColorectal CancerGastric Cancer or Gastroesophageal Junction Adenocarcinoma+2 more Qilu Pharmaceutical Co., Ltd. 300
Large-scale testing (Phase 3)Looking for participantsNCT07043400What this trial is testingInvestigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaWho this might be right forMetastatic Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma BeOne Medicines 351
Early research (Phase 1)Looking for participantsNCT04389632What this trial is testingSigvotatug Vedotin in Advanced Solid TumorsWho this might be right forCarcinoma, Non-Small Cell LungSquamous Cell Carcinoma of Head and NeckHER2 Negative Breast Neoplasms+9 more Seagen, a wholly owned subsidiary of Pfizer 1,006
Large-scale testing (Phase 3)Not Yet RecruitingNCT06944496What this trial is testingDisitamab Vedotin Combined With Tislelizumab and Chemotherapy Versus Tislelizumab Combined With Chemotherapy in HER2-Low Advanced Gastric or Gastroesophageal Junction AdenocarcinomaWho this might be right forGastric Carcinoma RemeGen Co., Ltd. 616
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06586294What this trial is testingAnti-PD-1 and LAG-3 Bispecific Antibody(AK129) Combined With Chemotherapy With or Without Cadonilimab in the First-line Treatment of Unresectable Locally Advanced or Metastatic G/ GEJ AdenocarcinomaWho this might be right forGastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma Akeso 294
Large-scale testing (Phase 3)UnknownNCT05919381What this trial is testingGentuximab Combined With Paclitaxel Compared With Placebo Combined With Paclitaxel for Gastric Adenocarcinoma.Who this might be right forAdenocarcinoma of Stomach Changchun GeneScience Pharmaceutical Co., Ltd. 752
Testing effectiveness (Phase 2)Looking for participantsNCT07325630What this trial is testingPerioprative Study of IBI363 in Patients With MHC-II-Negative Locally Advanced Gastric CancerWho this might be right forIBI363 + Chemotherapy Zhejiang Cancer Hospital 60
Testing effectiveness (Phase 2)Study completedNCT01611857What this trial is testingPhase I/II Trial of Tivantinib With FOLFOX for the Treatment of Advanced Solid Tumors and Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction or StomachWho this might be right forMalignant Solid TumourGastroesophageal Cancer SCRI Development Innovations, LLC 49
Testing effectiveness (Phase 2)Looking for participantsNCT03539822What this trial is testingCabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal MalignanciesWho this might be right forGastric CancerEsophageal AdenocarcinomaHepatocellular Carcinoma+1 more Anwaar Saeed 117
Testing effectiveness (Phase 2)Study completedNCT03686488What this trial is testingTAS 102 in Combination With Ramucirumab in Advanced, Refractory Gastric or Gastroesophageal Junction (GEJ) AdenocarcinomaWho this might be right forGastric AdenocarcinomaGastroesophageal Junction AdenocarcinomaGastric Cancer H. Lee Moffitt Cancer Center and Research Institute 23